Your browser doesn't support javascript.
loading
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Lepletier, Ailin; Madore, Jason; O'Donnell, Jake S; Johnston, Rebecca L; Li, Xian-Yang; McDonald, Elizabeth; Ahern, Elizabeth; Kuchel, Anna; Eastgate, Melissa; Pearson, Sally-Ann; Mallardo, Domenico; Ascierto, Paolo A; Massi, Daniela; Merelli, Barbara; Mandala, Mario; Wilmott, James S; Menzies, Alexander M; Leduc, Charles; Stagg, John; Routy, Bertrand; Long, Georgina V; Scolyer, Richard A; Bald, Tobias; Waddell, Nicola; Dougall, William C; Teng, Michele W L; Smyth, Mark J.
Afiliación
  • Lepletier A; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Queensland, Australia.
  • Madore J; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Queensland, Australia.
  • O'Donnell JS; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Queensland, Australia.
  • Johnston RL; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Queenland, Australia.
  • Li XY; School of Medicine, University of Queensland, Queensland, Australia.
  • McDonald E; Medical Genomics, QIMR Berghofer Medical Research Institute, Queensland, Australia.
  • Ahern E; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Queensland, Australia.
  • Kuchel A; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Queenland, Australia.
  • Eastgate M; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Queensland, Australia.
  • Pearson SA; School of Medicine, University of Queensland, Queensland, Australia.
  • Mallardo D; Department of Medical Oncology, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia.
  • Ascierto PA; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Queensland, Australia.
  • Massi D; School of Medicine, University of Queensland, Queensland, Australia.
  • Merelli B; Department of Medical Oncology, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia.
  • Mandala M; School of Medicine, University of Queensland, Queensland, Australia.
  • Wilmott JS; Department of Medical Oncology, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia.
  • Menzies AM; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Queensland, Australia.
  • Leduc C; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
  • Stagg J; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
  • Routy B; Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
  • Long GV; Department of Oncology and Haematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Scolyer RA; Department of Oncology and Haematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Bald T; Melanoma Institute Australia, The University of Sydney, New South Wales, Australia.
  • Waddell N; Melanoma Institute Australia, The University of Sydney, New South Wales, Australia.
  • Dougall WC; Department of Pathology, University of Montreal Health Center, Montreal, Quebec, Canada.
  • Teng MWL; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Queensland, Australia.
  • Smyth MJ; Research Centre, University of Montreal Hospital, Montreal, Canada.
Clin Cancer Res ; 26(14): 3671-3681, 2020 07 15.
Article en En | MEDLINE | ID: mdl-32345648
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptores Virales / Neoplasias Cutáneas / Regulación Neoplásica de la Expresión Génica / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptores Virales / Neoplasias Cutáneas / Regulación Neoplásica de la Expresión Génica / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Australia